Exploration of a F(ab′)2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy

Cancer Biotherapy and Radiopharmaceuticals, Volume 33, Issue 5, Page 182-193, June 2018.


https://ift.tt/2t7byHk